Search Results for 'hiv inh'
hiv inh published presentations and documents on DocSlides.
Discovery Novel Allosteric Fragment Inhibitors of HIV-1 Rev
by sherrill-nordquist
. A/Prof Gilda Tachedjian. Retroviral Biolo...
Interferon-induced HERC5 protein inhibits HIV-1 replication
by phoebe-click
. Matthew Woods (Western University, Canada: Bar...
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
The 12-Dose INH-Rifapentine Once-Weekly DOT Regimen:
by briana-ranney
What Next?. CTCA Conference 2012. John Jereb, FSE...
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold).
by alida-meadow
One sneeze can generate an aerosol of enough cold...
Recent Developments in AIDS Diagnosis & Treatment
by myesha-ticknor
Presented by Joyce Lee, . Kobika. . Thiyagasothy...
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and
by warlikebikers
IMPAACT . 2001 STUDY . Mhembere T.P. (B. Pharm . (...
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic
by rosemary
Rama . Karadsheh. . 1. , and Megan . Meuser. . 1...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
HIV/AIDS Psychiatric Illness & Treatment
by lydia
APM Resident Education Curriculum. Karina . Uldall...
Chapter 21 Care of Patients with HIV Disease and Other Immune Deficiencies
by jalin
Acquired Immune Deficiency Syndrome. The most comm...
Community Pharmacy Considerations for HIV
by tawny-fly
& HCV . Therapy. Larry Pineda, . PharmD. , . ...
HIV Pharmacotherapy Focused Update
by sherrill-nordquist
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
HIV/AIDS 2014 Basic Definitions
by alexa-scheidler
AIDS – Acquired Immunodeficiency Syndrome. Fina...
Stillbirth in HIV-infected women delivering in UK/Ireland between 2007 and 2015
by yoshiko-marsland
G. . . Favarato. , . R.Sconza. , . H. . . Peters,...
Track B Workshop Controversies in the Management of HIV-positive Adults:
by natalia-silvester
A Case-Based Approach. Sasisopin Kiertiburanakul,...
HIV Medicine From Guidelines to Practice
by cheryl-pisano
Kiat. . Ruxrungtham. Professor of Medicine, . Ch...
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
by sherrill-nordquist
± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
Antiretroviral Agents: HIV & AIDS
by min-jolicoeur
Shaw Vonder Hoya. Worldwide Prevalence. Types of ...
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
Chemokine Receptor 5 Inhibition Prevents SIV-associated Cardiac Dysfunction
by martin
Katie Kelly Brennan, DVM. Johns Hopkins University...
Breathe Pennsylvania: Tuberculosis Educational Conf
by jade
.. April. 24, 2015. Ed . Zuroweste, MD. . PA ...
HIV Pipeline Doravirine 2
by giovanna-bartolotta
(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...
Global Health Case Studies –
by myesha-ticknor
HIV . and Tuberculosis. Clinical Pearls in Diagno...
SQV and LPV-RTV in Treatment-Experienced Children HIV-NAT 017
by stone946
HIV-NAT . 017. SQV and . LPV-RTV . in Treatment-Ex...
InhibitsHIV1ReplicationinPeripheralBloodMonocytesandAlveolarMacrophag
by kylie
DepartmentofInternalMedicine,Divisionsof*Infectiou...